Jounce Therapeutics, Inc. (JNCE) has 49 open-market insider trades by 13 insiders since 2017. The most active filer is Kimberlee C. Drapkin, CFO & Treasurer.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| TRV GP Iii, LLC | 10% Owner | — | 1 | $31.8M | 2021-11-12 |
| Kevin P. Starr | 10% Owner | — | 1 | $17.0M | 2021-06-10 |
| Celgene Corp. /de/ | 10% Owner | — | 1 | $10.0M | 2017-02-01 |
| TRV GP Ii, LLC | 10% Owner | — | 2 | $4.5M | 2021-05-25 |
| Richard /ca/ Murray | Dir | — | 9 | $3.1M | 2023-05-03 |
| Kimberlee C. Drapkin | CFOTreasurer | — | 10 | $809K | 2023-05-03 |
| Elizabeth Trehu | — | — | 10 | $539K | 2023-01-10 |
| Hugh M. Cole | — | — | 8 | $398K | 2023-01-10 |
| Barbara Gayle Duncan | Dir | — | 3 | $209K | 2020-09-15 |
| TANG Capital Management LLC | 10% Owner | — | 1 | $151K | 2023-03-14 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Richard /ca/ Murray | Director | Sell | $145K | 2023-04-04 |
| TANG Capital Management LLC | 10% Owner | Buy | $151K | 2023-03-13 |
| Elizabeth Trehu | Chief Medical Officer | Sell | $10K | 2023-01-09 |
| Kimberlee C. Drapkin | Treasurer | Sell | $16K | 2023-01-09 |
| Hugh M. Cole | COO | Sell | $18K | 2023-01-09 |
| Richard /ca/ Murray | President | Sell | $50K |
Companies that share insiders with JNCE, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2023-01-09 |
| Richard /ca/ Murray | CEO & President | Sell | $416K | 2022-01-07 |
| Kimberlee C. Drapkin | CFO & Treasurer | Sell | $143K | 2022-01-07 |
| Hugh M. Cole | Chief Business Officer | Sell | $67K | 2022-01-07 |
| Elizabeth Trehu | Chief Medical Officer | Sell | $58K | 2022-01-07 |
| TRV GP Iii, LLC | 10% Owner | Sell | $31.8M | 2021-11-12 |
| TRV GP Ii, LLC | 10% Owner | Sell | $4.4M | 2021-05-25 |
| John Duncan Higgons | Director | Sell | $2K | 2021-04-15 |
| Elizabeth Trehu | — | Sell | $136K | 2021-03-29 |
| John Duncan Higgons | Director | Sell | $3K | 2021-03-15 |